Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

CAR - T CD19/CD20/CD22/CD30

Tundra lists 1 CAR - T CD19/CD20/CD22/CD30 clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT03196830

CAR-T for R/R B-NHL

This study is a single arm study to investigate the efficacy and safety of CAR-T targeted CD19/CD20/CD22/CD30 in relapse and refractory non-Hodgkin lymphoma patients. Ten patients will recruieted, admitted in hospital for 1 month for the CAR-T treatment and follow-up for at least 2 years.

Gender: All

Ages: 6 Years - 65 Years

Updated: 2026-06-03

1 state

Relapsed Non Hodgkin Lymphoma

Refractory Non-Hodgkin Lymphoma

CAR - T CD19/CD20/CD22/CD30